Get the Stockscreener App
8.54
1.16%
-0.10
Pre-market:
8.58
0.04
+0.47%
Evolent Health Inc stock is traded at $8.54, with a volume of 6.04M.
It is down -1.16% in the last 24 hours and down -8.17% over the past month.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
See More
Previous Close:
$8.64
Open:
$8.64
24h Volume:
6.04M
Relative Volume:
1.93
Market Cap:
$1.00B
Revenue:
$2.35B
Net Income/Loss:
$-74.42M
P/E Ratio:
-9.0851
EPS:
-0.94
Net Cash Flow:
$150.93M
1W Performance:
-7.07%
1M Performance:
-8.17%
6M Performance:
-14.51%
1Y Performance:
-72.04%
1-Day Range:
$8.425
$8.84
1-Week Range:
$8.425
$9.375
52-Week Range:
$7.06
$31.67
Evolent Health Inc Stock (EVH) Company Profile
Name
Evolent Health Inc
Sector
Industry
Phone
571-389-6000
Address
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
8.54 | 1.00B | 2.35B | -74.42M | 150.93M | -0.94 |
|
VEEV
Veeva Systems Inc
|
274.58 | 44.89B | 2.97B | 809.93M | 1.33B | 4.87 |
|
TEM
Tempus Ai Inc
|
86.45 | 15.12B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
72.67 | 13.50B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
92.28 | 7.89B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
38.59 | 6.66B | 906.14M | -52.62M | 89.62M | -0.3621 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Initiated | Needham | Buy |
| Dec-03-24 | Reiterated | BTIG Research | Buy |
| Nov-08-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-09-24 | Upgrade | Truist | Hold → Buy |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-01-24 | Initiated | Oppenheimer | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-23 | Initiated | UBS | Buy |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Nov-01-22 | Initiated | Truist | Hold |
| Jul-29-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Nov-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-29-21 | Resumed | JP Morgan | Neutral |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Jul-06-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-05-20 | Downgrade | Goldman | Buy → Neutral |
| Jun-02-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-05-18 | Resumed | Leerink Partners | Outperform |
| Jun-04-18 | Initiated | Piper Jaffray | Overweight |
| Apr-24-18 | Resumed | JP Morgan | Neutral |
| Sep-20-17 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-02-17 | Initiated | Robert W. Baird | Outperform |
| Mar-14-17 | Initiated | Oppenheimer | Outperform |
| Jan-13-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Oct-28-16 | Resumed | JP Morgan | Overweight |
| Aug-05-16 | Reiterated | FBR Capital | Outperform |
| Jul-26-16 | Initiated | Jefferies | Buy |
| Jul-13-16 | Reiterated | FBR Capital | Outperform |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
| Jan-06-16 | Initiated | Canaccord Genuity | Buy |
| Jun-30-15 | Initiated | Goldman | Buy |
| Jun-30-15 | Initiated | JP Morgan | Overweight |
| Jun-30-15 | Initiated | Leerink Partners | Outperform |
| Jun-30-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Evolent Health Inc Stock (EVH) Latest News
CVS vs. EVH: Which Value-Based Care Stock Deserves Investor Attention? - sharewise.com
What’s the outlook for Evolent Health Inc.’s sectorPortfolio Value Summary & Real-Time Volume Spike Alerts - خودرو بانک
Will Evolent Health Inc benefit from geopolitical trendsQuarterly Portfolio Review & Safe Swing Trade Setup Alerts - خودرو بانک
Salem Investment Counselors Inc. Cuts Position in Evolent Health, Inc $EVH - MarketBeat
Activity Recap: How correlated is Evolent Health Inc. to the S&P5002025 Technical Patterns & Fast Entry Momentum Trade Alerts - خودرو بانک
Investor Mood: Is Evolent Health Inc part of any major indexPortfolio Risk Report & Precise Swing Trade Entry Alerts - خودرو بانک
Profit Review: Does Evolent Health Inc have a sustainable dividendJuly 2025 Earnings & Fast Gaining Stock Reports - خودرو بانک
Evolent Health gains as activist Engaged Capital reaches cooperation agreement - MSN
Evolent Health (EVH) Is Down 6.7% After Weak Q2 Results and Lower Revenue – Has the Bull Case Changed? - Yahoo Finance
Evolent Health (NYSE:EVH) Trading Down 5.8%Should You Sell? - MarketBeat
Canaccord Genuity Group Reiterates Buy Rating for Evolent Health (NYSE:EVH) - MarketBeat
Evolent Health (NYSE:EVH) Receives Buy Rating from BTIG Research - MarketBeat
Evolent Health (NYSE:EVH) Is Making Moderate Use Of Debt - 富途牛牛
Evolent Health, Inc $EVH Shares Sold by Adage Capital Partners GP L.L.C. - MarketBeat
Healthcare Technology for Providers Stocks Q2 Recap: Benchmarking Evolent Health (NYSE:EVH) - Yahoo Finance
Philosophy Capital Management LLC Has $4.94 Million Stock Position in Evolent Health, Inc $EVH - MarketBeat
ResMed, Insulet, Lantheus, Inspire Medical Systems, and Evolent Health Shares Plummet, What You Need To Know - Barchart.com
Granahan Investment Management LLC Sells 2,311,880 Shares of Evolent Health, Inc $EVH - MarketBeat
Evolent Health (EVH) Maintains Buy Rating by Canaccord Genuity | - GuruFocus
BTIG Reiterates Buy Rating for Evolent Health (EVH) with $20 Tar - GuruFocus
CCORF Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $16 - 富途牛牛
Eventide Asset Management LLC Boosts Stock Holdings in Evolent Health, Inc $EVH - MarketBeat
Quant Strategy Flags Evolent Health Inc. for Entry2025 Bull vs Bear & Accurate Buy Signal Alerts - beatles.ru
What’s the beta of Evolent Health Inc. stockShare Buyback & Low Risk Growth Stock Ideas - classian.co.kr
Evolent Health prices convertible notes offering - MSN
Evolent Health, Inc. Announces Proposed Offering of $140.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock - ADVFN Brasil
Evolent Announces Second Quarter 2025 Results - ADVFN Brasil
Evolent Health, Inc. Announces Pricing of Oversubscribed and Upsized $145.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock - ADVFN Brasil
What recovery options are there for Evolent Health Inc.Trade Exit Report & Growth Focused Entry Reports - Newser
Can volume confirm reversal in Evolent Health Inc.Analyst Upgrade & Community Verified Watchlist Alerts - Newser
Evolent Health, Inc (NYSE:EVH) Receives $18.07 Average Price Target from Analysts - MarketBeat
Full technical analysis of Evolent Health Inc. stockTrend Reversal & Safe Capital Growth Trade Ideas - Newser
What are Evolent Health Inc.’s technical support levelsJuly 2025 Outlook & Verified Chart Pattern Trade Signals - خودرو بانک
What is Evolent Health Inc.’s TAM (Total Addressable Market)2025 Short Interest & Stepwise Entry and Exit Trade Signals - خودرو بانک
How volatile is Evolent Health Inc. stockJuly 2025 Setups & Long-Term Capital Growth Strategies - خودرو بانک
Technical signs of recovery in Evolent Health Inc.2025 Top Gainers & Verified Momentum Stock Alerts - Newser
Evolent Health Inc. stock chart pattern explained2025 Trading Recap & Fast Gaining Stock Strategy Reports - Newser
Invesco Ltd. Sells 947,128 Shares of Evolent Health, Inc $EVH - MarketBeat
Using flow based indicators on Evolent Health Inc.Market Sentiment Report & AI Forecast Swing Trade Picks - Newser
What machine learning models say about Evolent Health Inc.Global Markets & Proven Capital Preservation Tips - Newser
What is Evolent Health Inc. s 5 year growth outlookWeekly Trade Summary & Reliable Momentum Entry Alerts - خودرو بانک
Risk adjusted return profile for Evolent Health Inc. analyzedDay Trade & AI Enhanced Execution Alerts - Newser
Hsbc Holdings PLC Increases Position in Evolent Health, Inc $EVH - MarketBeat
What is the long term forecast for Evolent Health Inc. stock2025 Investor Takeaways & Weekly Watchlist for Consistent Profits - خودرو بانک
Will breakout in Evolent Health Inc. lead to full recoveryWeekly Risk Report & Fast Exit Strategy with Risk Control - Newser
Statistical indicators supporting Evolent Health Inc.’s strengthWall Street Watch & Real-Time Chart Breakout Alerts - Newser
What to do if you’re stuck in Evolent Health Inc.2025 Geopolitical Influence & Expert-Curated Trade Recommendations - Newser
Will Evolent Health Inc. continue its uptrendJuly 2025 Price Swings & Expert Curated Trade Setup Alerts - Newser
Detecting price anomalies in Evolent Health Inc. with AIEarnings Summary Report & AI Driven Stock Movement Reports - Newser
Understanding Evolent Health Inc.’s price movementWeekly Trend Report & Low Risk High Win Rate Stock Picks - Newser
Building trade automation scripts for Evolent Health Inc.2025 Earnings Impact & Fast Moving Trade Plans - Newser
Evolent Health Inc Stock (EVH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
0.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):